Famitinib

CAS No. 945380-27-8

Famitinib( SHR 1020 )

Catalog No. M16770 CAS No. 945380-27-8

Famitinib (SHR1020) is a structural analogue of sunitinib, novel and potent multi-targeted RTK inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Famitinib
  • Note
    Research use only, not for human use.
  • Brief Description
    Famitinib (SHR1020) is a structural analogue of sunitinib, novel and potent multi-targeted RTK inhibitor.
  • Description
    Famitinib (SHR1020) is a structural analogue of sunitinib, novel and potent multi-targeted RTK inhibitor, including c-Kit, VEGFR2/3, PDGFRβ, FLT-1/3 receptor and c-RET; demonstrates the higher potency in tumour growth inhibition in human tumour xenograft models compared with sunitinib.Colon Cancer Phase 3 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SHR 1020
  • Pathway
    Angiogenesis
  • Target
    c-Kit
  • Recptor
    c-Kit
  • Research Area
    Cancer
  • Indication
    Colon Cancer

Chemical Information

  • CAS Number
    945380-27-8
  • Formula Weight
    410.493
  • Molecular Formula
    C23H27FN4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCN(CC)CCN1CCC2=C(C1=O)C(=C(N2)C=C3C4=C(C=CC(=C4)F)NC3=O)C
  • Chemical Name
    (Z)-5-(2-(diethylamino)ethyl)-2-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-3-methyl-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Xie C, et al. Br J Pharmacol. 2013 Apr;168(7):1687-706. 2. Zhang W, et al. Chin Med J (Engl). 2013 Nov;126(22):4277-81. 3. Zhou A, et al. Cancer Chemother Pharmacol. 2013 Nov;72(5):1043-53. 4. Ge S, et al. Oncol Lett. 2016 Sep;12(3):1763-1768.
molnova catalog
related products
  • Bezuclastinib

    Bezuclastinib (CGT9486) is a novel, potent and highly selective tyrosine kinase and c-kit D816V inhibitor for the study of advanced mastocytosis.

  • Katacine

    Katacine inhibits of oxygen consumption and suppresses the speed of electrons transfer from oxidation substrates via respiratory chain of mitochondria to molecular oxygen.

  • CS-2660

    CS-2660, a highly selective, orally available, well tolerated VEGFR2 inhibitor with IC50 of 40 nM, inhibits closely related tyrosine kinases such as Ret and Kit with IC50 of 180 nM and 500 nM.